Literature DB >> 9679540

Thioredoxin redox control of cell growth and death and the effects of inhibitors.

G Powis1, D L Kirkpatrick, M Angulo, A Baker.   

Abstract

Thioredoxin is a redox protein found over-expressed in some human tumors. Thioredoxin is secreted by tumor cells and stimulates cancer cell growth. Redox activity is essential for growth stimulation by thioredoxin. Cells transfected with thioredoxin cDNA show increased tumor growth and decreased apoptosis in vivo and decreased sensitivity to apoptosis induced by a variety of agents both in vitro and in vivo. Cells transfected with a redox-inactive mutant thioredoxin show inhibited tumor growth in vivo. Thus, thioredoxin offers an attractive target for anticancer drug development. A class of disulfide inhibitors of thioredoxin has been identified. These disulfides inhibit cancer cell growth in culture and have antitumor activity against some human tumor xenografts in animals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9679540     DOI: 10.1016/s0009-2797(97)00148-8

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  20 in total

1.  Tissue thioredoxin reductase-1 expression in astrocytomas of different grades.

Authors:  Hasan Esen; Fatih Erdi; Bulent Kaya; Bahadır Feyzioglu; Fatih Keskin; Lutfi Saltuk Demir
Journal:  J Neurooncol       Date:  2014-11-13       Impact factor: 4.130

Review 2.  Glutathione S-transferases as regulators of kinase pathways and anticancer drug targets.

Authors:  Danyelle M Townsend; Victoria L Findlay; Kenneth D Tew
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

3.  Antioxidant enzymes in oligodendroglial brain tumors: association with proliferation, apoptotic activity and survival.

Authors:  Sally Järvelä; Järvelä Sally; Helena Bragge; Bragge Helena; Niina Paunu; Paunu Niina; Timo Järvelä; Järvelä Timo; Leo Paljärvi; Paljärvi Leo; Hannu Kalimo; Kalimo Hannu; Pauli Helén; Helén Pauli; Vuokko Kinnula; Kinnula Vuokko; Ylermi Soini; Soini Ylermi; Hannu Haapasalo; Haapasalo Hannu
Journal:  J Neurooncol       Date:  2006-04       Impact factor: 4.130

4.  Internal thiols and reactive oxygen species in candidacidal activity exerted by an N-terminal peptide of human lactoferrin.

Authors:  Antonella Lupetti; Akke Paulusma-Annema; Sonia Senesi; Mario Campa; Jaap T Van Dissel; Peter H Nibbering
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

5.  The conserved redox-sensitive cysteine residue of the DNA-binding region in the c-Rel protein is involved in the regulation of the phosphorylation of the protein.

Authors:  C Glineur; E Davioud-Charvet; B Vandenbunder
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

6.  Regulation of the activity of the tumor suppressor PTEN by thioredoxin in Drosophila melanogaster.

Authors:  Zuohe Song; Negin Saghafi; Vijay Gokhale; Marc Brabant; Emmanuelle J Meuillet
Journal:  Exp Cell Res       Date:  2007-01-12       Impact factor: 3.905

7.  Decreased expression of antioxidant enzymes is associated with aggressive features in ependymomas.

Authors:  Sally Järvelä; Kristiina Nordfors; Miia Jansson; Joonas Haapasalo; Pauli Helén; Leo Paljärvi; Hannu Kalimo; Vuokko Kinnula; Ylermi Soini; Hannu Haapasalo
Journal:  J Neurooncol       Date:  2008-08-06       Impact factor: 4.130

8.  Redox Regulation of Apoptosis before and after Cytochrome C Release.

Authors:  Quan Chen; Meredith Crosby; Alex Almasan
Journal:  Korean J Biol Sci       Date:  2003-03

9.  A novel thioredoxin reductase inhibitor inhibits cell growth and induces apoptosis in HL-60 and K562 cells.

Authors:  Zuo-Fu Peng; Lin-Xiang Lan; Fang Zhao; Jing Li; Qiang Tan; Han-Wei Yin; Hui-Hui Zeng
Journal:  J Zhejiang Univ Sci B       Date:  2008-01       Impact factor: 3.066

10.  Inhibition of glutathione and thioredoxin metabolism enhances sensitivity to perifosine in head and neck cancer cells.

Authors:  Andrean L Simons; Arlene D Parsons; Katherine A Foster; Kevin P Orcutt; Melissa A Fath; Douglas R Spitz
Journal:  J Oncol       Date:  2009-09-02       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.